UC Research Should Be Free to All: COVID-19 Shows Us Why

UC Research Should Be Free to All: COVID-19 Shows Us Why

10/16/20 11:30 a.m.12:30 p.m.  

The University of California has long believed that its research should be free for all to access. A world without barriers to knowledge promotes progress — including in the critically important fields of healthcare and medicine — and maximizes the impact of research. Since the pandemic struck, research on the novel coronavirus has been shared freely worldwide. In this panel discussion, Britt Glaunsinger, professor and researcher who specializes in viruses, Jeff MacKie-Mason, university librarian and professor, and Randy Schekman, Nobel Laureate and professor, explain why we should never go back to our old ways of scientific publishing.

Britt Glaunsinger
Professor, Plant and Microbial Biology and Molecular and Cellular Biology

Glaunsinger is a UC Berkeley professor in the Department of Plant & Microbial Biology and the Department of Molecular & Cellular Biology and is also a Howard Hughes Medical Institute investigator.

Jeff MacKie-Mason
University Librarian; Chief Digital Scholarship Officer; and Professor, Economics and Information

MacKie-Mason is UC Berkeley’s university librarian, chief digital scholarship officer, and a professor of economics and information. He is co-chair of the UC-wide task force that negotiates with academic publishers.

Randy Schekman
Professor, Cell and Developmental Biology and Investigator, Howard Hughes Medical Institute

Schekman is a UC Berkeley professor of cell and developmental biology, a Howard Hughes Medical Institute investigator, and recipient of the 2013 Nobel Prize in Physiology or Medicine.

Rachael Samberg (Moderator)
Scholarly Communication Officer, UC Berkeley Library

Samberg leads the UC Berkeley Library’s Office of Scholarly Communication Services, which helps scholars navigate the shifting publishing, intellectual property, and information policy landscapes.

Sponsored by: 
UC Berkeley Library